2012
DOI: 10.1038/leu.2012.139
|View full text |Cite
|
Sign up to set email alerts
|

Oncogenic fusion E2A-HLF sensitizes t(17;19)-positive acute lymphoblastic leukemia to TRAIL-mediated apoptosis by upregulating the expression of death receptors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
16
0

Year Published

2012
2012
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 16 publications
(17 citation statements)
references
References 49 publications
1
16
0
Order By: Relevance
“…Moreover, pathway analysis of our most significant genes revealed overlap with several transcription factors, including MAZ, TCF3, SP1, LEF1, which are all implicated at various degrees in cell-cycle regulation and cancer development. 50,51,[61][62][63] Further studies should investigate the putative mechanisms of folate on these transcription factors' activity, as they might be implicated in the pathogenesis of cancer development, especially those that develop in utero.…”
Section: Discussionmentioning
confidence: 99%
“…Moreover, pathway analysis of our most significant genes revealed overlap with several transcription factors, including MAZ, TCF3, SP1, LEF1, which are all implicated at various degrees in cell-cycle regulation and cancer development. 50,51,[61][62][63] Further studies should investigate the putative mechanisms of folate on these transcription factors' activity, as they might be implicated in the pathogenesis of cancer development, especially those that develop in utero.…”
Section: Discussionmentioning
confidence: 99%
“…The t(17;19) (q22;p13) translocation generates the E2A-HLF chimeric transcription factor and is associated with a poor prognosis [ 17 ]. E2A-HLF can block apoptosis induced by the intrinsic mitochondrial pathway and has a central role in leukemogenesis and chemoresistance [ 18 ]. This has consistently been associated with hypercalcaemia, acquired coagulation abnormalities and DIC and chemorefractory disease.…”
Section: Discussionmentioning
confidence: 99%
“…Seventy‐nine BCP‐ALL cell lines were analyzed, which included 14 Philadelphia chromosome‐positive (Ph+) cell lines (KOPN30bi, 55bi, 56, 57bi, 66bi, 72bi, 83bi, YAMN73, 91, KCB1, Nalm27, SU‐Ph2, TCCS, SK9), 11 MLL ‐rearranged ( MLL +) cell lines (KOPN1, KOPB26, KOCL33, 44, 45, 50, 51, 58, 69, YACL95, RS4;11), 16 t(1;19)‐ALL cell lines (KOPNK, 34, 36, 54, 60, 63, YAMN90, 92, YCUB6, YCUB8, Kasumi2, THP4, SCMCL1, 697, RCH, PreALP), 4 t(17;19)‐ALL cell lines (UOC‐B1, HALO1, YCUB2, Endo‐kun), 3 t(12;21)‐ALL cell lines (KOPN41, 79, Reh), and 31 other cell lines (KOS20, KOPN32, 39, 35, 41, 49, 61, 62, 68, 70, 71, 75, 79, 84, 85, KCB4, YAMN74, THP5, 7, 8, YCUB4, 5, 7, MBKG, MBMY, MBOK, L‐ASK, L‐KUM, SCMCL2, P30/OHK, Nalm6). Seven BCP‐ALL cell lines (RS4;11, 697, RCH, PreALP, UOC‐B1, Reh, and Nalm6) were established from non‐Japanese patients, whereas seventy‐two BCP‐ALL cell lines were established from Japanese patients , All cell lines were maintained in RPMI1640 medium supplemented with 10% fetal calf serum in a humidified atmosphere of 5% CO 2 at 37°C.…”
Section: Methodsmentioning
confidence: 99%
“…and 31 other cell lines (KOS20, KOPN32, 39, 35, 41, 49, 61, 62, 68, 70, 71, 75, 79, 84, 85, KCB4, YAMN74, THP5, 7, 8, YCUB4, 5, 7, MBKG, MBMY, MBOK, L-ASK, L-KUM, SCMCL2, P30/OHK, Nalm6). Seven BCP-ALL cell lines (RS4;11, 697, RCH, PreALP, UOC-B1, Reh, and Nalm6) were established from non-Japanese patients, whereas seventy-two BCP-ALL cell lines were established from Japanese patients [16][17][18][19], All cell lines were maintained in RPMI1640 medium supplemented with 10% fetal calf serum in a humidified atmosphere of 5% CO 2 at 37°C.…”
Section: Introductionmentioning
confidence: 99%